Companhia de Saneamento de Minas Gerais (CSMG3) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
11 May, 2026Executive summary
Net revenue reached BRL 1.91 billion in Q1 2026, up 2.5% year-over-year, driven by a 6.56% tariff adjustment and stable water/sewage volumes.
EBITDA was BRL 787 million, down 3.2% year-over-year, with a margin of 40.9%; net income fell 14.1% to BRL 368 million due to higher costs and financial expenses.
CapEx increased 28% to BRL 695 million, supporting water and sewage system expansion and modernization.
Regulatory predictability improved with the third regulatory review, 6.56% tariff increase, and renewal of the Belo Horizonte concession until 2073.
Operational transformation initiatives included centralized operations, workforce resizing, and energy cost optimization.
Financial highlights
Net revenue: BRL 1.91 billion (+2.5% YoY); EBITDA: BRL 787 million (-3.2% YoY); EBITDA margin: 40.9% (-240 bps); Net income: BRL 368 million (-14.1% YoY).
Costs and expenses (excluding D&A): BRL 1.06 billion (+4.7% YoY); CapEx: BRL 695 million (+28% YoY).
Cash from operations: BRL 675.1 million (-1.5% YoY).
Net debt rose 32% to BRL 7.1 billion; leverage increased to 2.4x EBITDA.
Dividend payout for Q1 2026 was BRL 177.6 million.
Outlook and guidance
Regulatory environment improved with the 3rd Tariff Review, setting a 6.56% tariff increase and a pre-tax WACC of 13.7% for 2026–2029.
Continued focus on operational efficiency, cost discipline, and investment in modernization and water security.
Concession with Belo Horizonte extended to 2073, with BRL 1.3 billion grant and BRL 300 million settlement to be paid between 2026–2028.
Reservoir levels in the Paraopeba System recovered to 83.5% capacity; no municipalities under water rationing as of May 2026.
Delinquency rates expected to normalize, with new collection initiatives underway.
Latest events from Companhia de Saneamento de Minas Gerais
- Strong revenue, profit, and CapEx growth, with regulatory and privatization advances.CSMG3
Q4 20258 Apr 2026 - Net income up 30.4% and EBITDA margin at 41.4%, with robust investments and higher dividends.CSMG3
Q2 20242 Feb 2026 - Net revenue up 9.6%, EBITDA margin at 40.5%, and net income up 9.3%.CSMG3
Q3 202416 Jan 2026 - Record investments, strong EBITDA, and high dividends highlight robust 2024 results.CSMG3
Q4 202426 Dec 2025 - Record EBITDA, net income, and lowest delinquency rate, with investments up 45.9%.CSMG3
Q1 202526 Nov 2025 - Revenue up, profit down; investments and efficiency gains amid higher leverage.CSMG3
Q2 202523 Nov 2025 - Record CapEx and stable EBITDA margin, with improved leverage and privatization progress.CSMG3
Q3 202513 Nov 2025